$53.27
0.74% day before yesterday
Nasdaq, Nov 01, 09:00 pm CET
ISIN
US80105N1054
Symbol
SNY
Sector
Industry

Sanofi Sponsored ADR Target price 2024 - Analyst rating & recommendation

Sanofi Sponsored ADR Classifications & Recommendation:

Buy
76%
Hold
14%
Sell
10%

Sanofi Sponsored ADR Price Target

Target Price $62.15
Price $53.27
Potential
Number of Estimates 18
18 Analysts have issued a price target Sanofi Sponsored ADR 2025 . The average Sanofi Sponsored ADR target price is $62.15. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 21 analysts: 16 Analysts recommend Sanofi Sponsored ADR to buy, 3 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sanofi Sponsored ADR stock has an average upside potential 2025 of . Most analysts recommend the Sanofi Sponsored ADR stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Billion $ 46.56 50.54
3.04% 8.54%
EBITDA Margin 30.09% 28.91%
5.78% 3.92%
Net Margin 12.52% 14.80%
35.58% 18.21%

16 Analysts have issued a sales forecast Sanofi Sponsored ADR 2024 . The average Sanofi Sponsored ADR sales estimate is

$50.5b
Unlock
. This is
6.01% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$53.6b 12.49%
Unlock
, the lowest is
$44.1b 7.46%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $46.6b 3.04%
2024
$50.5b 8.54%
Unlock
2025
$53.8b 6.49%
Unlock
2026
$57.2b 6.29%
Unlock
2027
$62.1b 8.53%
Unlock
2028
$64.2b 3.45%
Unlock

14 Analysts have issued an Sanofi Sponsored ADR EBITDA forecast 2024. The average Sanofi Sponsored ADR EBITDA estimate is

$14.6b
Unlock
. This is
2.28% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$17.7b 18.49%
Unlock
, the lowest is
$11.8b 21.00%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $14.0b 2.91%
2024
$14.6b 4.29%
Unlock
2025
$16.5b 12.81%
Unlock
2026
$17.6b 6.50%
Unlock
2027
$19.3b 9.75%
Unlock
2028
$20.8b 7.76%
Unlock

EBITDA Margin

2023 30.09% 5.78%
2024
28.91% 3.92%
Unlock
2025
30.62% 5.91%
Unlock
2026
30.68% 0.20%
Unlock
2027
31.03% 1.14%
Unlock
2028
32.32% 4.16%
Unlock

12 Sanofi Sponsored ADR Analysts have issued a net profit forecast 2024. The average Sanofi Sponsored ADR net profit estimate is

$7.5b
Unlock
. This is
64.23% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$10.6b 133.18%
Unlock
, the lowest is
$6.4b 40.79%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $5.8b 33.62%
2024
$7.5b 28.28%
Unlock
2025
$10.0b 34.08%
Unlock
2026
$10.0b 0.22%
Unlock
2027
$10.9b 8.69%
Unlock
2028
$12.8b 17.58%
Unlock

Net Margin

2023 12.52% 35.58%
2024
14.80% 18.21%
Unlock
2025
18.63% 25.88%
Unlock
2026
17.49% 6.12%
Unlock
2027
17.51% 0.11%
Unlock
2028
19.91% 13.71%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share $ 2.33 2.99
33.62% 28.33%
P/E 17.82
EV/Sales 3.01

12 Analysts have issued a Sanofi Sponsored ADR forecast for earnings per share. The average Sanofi Sponsored ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$2.99
Unlock
. This is
64.29% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$4.24 132.97%
Unlock
, the lowest is
$2.56 40.66%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $2.33 33.62%
2024
$2.99 28.33%
Unlock
2025
$4.01 34.11%
Unlock
2026
$4.00 0.25%
Unlock
2027
$4.35 8.75%
Unlock
2028
$5.11 17.47%
Unlock

P/E ratio

Current 29.22 142.49%
2024
17.82 39.01%
Unlock
2025
13.29 25.42%
Unlock
2026
13.32 0.23%
Unlock
2027
12.26 7.96%
Unlock
2028
10.42 15.01%
Unlock

Based on analysts' sales estimates for 2024, the Sanofi Sponsored ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.19 17.71%
2024
3.01 5.69%
Unlock
2025
2.83 6.09%
Unlock
2026
2.66 5.92%
Unlock
2027
2.45 7.86%
Unlock
2028
2.37 3.33%
Unlock

P/S ratio

Current 2.80 17.40%
2024
2.64 5.67%
Unlock
2025
2.48 6.09%
Unlock
2026
2.33 5.92%
Unlock
2027
2.15 7.86%
Unlock
2028
2.08 3.33%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today